Skip to main content
Fig. 4 | Biomarker Research

Fig. 4

From: Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma

Fig. 4

Correlation of the ctDNA assessment with the patient clinical characteristics. a Linear regression of the plasma ctDNA concentration with metabolic tumor volume. b Mutation allele frequencies of KMT2D, APC, ATM, ASXL3 and JAK3 in patients with different tumor stages. c The correlation between plasma EBV-DNA levels and metabolic tumor volume. d The general metabolic tumor volume in patients with different mutation statuses of KMT2D, APC, ATM, ASXL3, JAK3 and TP53. e The correlation of the EBV-DNA level with the ctDNA concentration

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us